A recent study published in the Journal of Medical Toxicology finds a significant rise in hemp-derived delta-8 THC exposure in the United States, especially in states where cannabis is still illegal.

The study found that rates of delta-8 THC exposures reported to poison centers were 79 % higher in 2022 than in 2021, with the U. S. South accounting for over two-thirds of all cases. According to the study, states with stricter regulations or legalized cannabis use had significantly higher coverage rates than those with stricter laws or uncontrolled delta-8 THC.

Researchers from multiple institutions, including Nationwide Children’s Hospital and the Ohio State University, analyzed data from the National Poison Data System ( NPDS ) from January 2021 to December 2022.

According to the study, delta-8 THC contact rates were noticeably lower in states where marijuana use was permitted or prohibited. The authors wrote,” The price of delta-8-THC risks reported to Laptops was significantly lower in states where marijuana use was legal and where delta-8 was prohibited.”

State-level modifications

The highest number of poison centre reports were found in the South, a condition where selling recreational marijuana is illegal. These state, where delta-8 THC remains largely unregulated, reported a mean publicity level of 1.64 per 100, 000 people in 2022, in contrast to states with legalized hemp, which reported a charge of only 0.52 per 100, 000.

The research grouped says into three groups: those where delta-8 THC was illegal, those where it was restricted but no banned, and those where it was openly banned.

Also, cannabis position was broken down into six categories, based on whether medical or recreational pot was legitimate, and if those regulations changed during the study time. The results were constant: states with a legitimate cannabis construction, either medical or recreational, saw fewer delta-8 THC exposure.

In states where delta-8 THC was illegal, the mean exposure charge per 100, 000 persons stood at 1.36 in 2022, compared to only 0.17 in state that banned the cbd. The study’s authors argued that even regulation in all states may reduce health risks for citizens.

Common health and plan

The fall of delta-8 THC is generally attributed to the 2018 Farm Bill, which legalized cannabis and its compounds, creating a legal loophole that allowed delta-8 THC items to flood the market. This increase in supply, especially in states with tight delta-9 THC regulations, has contributed to delta-8’s fall as a substitute solution. ” In element, this is due to less business contest from delta-9-THC materials in states where their use was illegal”, the research information.

Delta-8 products most commonly appear as snacks or candies such as gummies. Producers have received criticism for packaging them in patterns that resemble well-known brands. The products, which are frequently found in gas stations and online, lack proper regulation, which leads to risks like contamination and inaccurate labeling.

Alarming reports

Although delta-8 is technically legal in many areas, the lack of federal oversight has raised safety concerns, particularly for children and teenagers. According to the study, 30 % of exposures involved children under the age of six, with some requiring hospitalization.

Despite growing concern, legislative action on delta-8 THC and other hemp intoxicants remains inconsistent. Some states are introducing regulations, while federal lawmakers, through amendments like Rep. Mary Miller’s proposal to the 2024 Farm Bill, are considering a ban on delta-8 and all other hemp-derived cannabinoids.

In order to reduce health risks, the study concludes by calling for national regulation of delta-8 THC. ” Although public policy efforts have focused more on delta-9-THC, our study’s findings support the need for adoption of consistent regulation of delta-8-THC across all states”, the authors write.

Springer Nature, based in London, publishes The Journal of Medical Toxicology on behalf of the American College of Medical Toxicology.

Skip to content